KRAS G12C MUTATION
Clinical trials for KRAS G12C MUTATION explained in plain language.
Never miss a new study
Get alerted when new KRAS G12C MUTATION trials appear
Sign up with your email to follow new studies for KRAS G12C MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Tailored drugs aim to shrink brain tumors in new trial
Disease control OngoingThis study tests whether genetic testing can help doctors choose the right drug for people whose cancer has spread to the brain. About 50 adults with solid tumors that have certain gene changes (like NTRK, ROS1, or KRAS) will receive a targeted pill. The goal is to see if these d…
Matched conditions: KRAS G12C MUTATION
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New hope for hard-to-treat colon cancer: targeted drug duo shows promise
Disease control ENROLLING_BY_INVITATIONThis study is testing two new drug combinations for people with a specific genetic mutation (KRAS G12C) in advanced colorectal cancer that has spread. One group gets the drugs as their first treatment, and another group gets them after standard treatment stops working. The goal i…
Matched conditions: KRAS G12C MUTATION
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 17, 2026 01:47 UTC
-
Scientists dig into genetic secrets of Drug-Resistant lung cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why certain lung cancers stop responding to targeted therapy (tyrosine kinase inhibitors). Researchers will analyze tumor tissue from 40 patients to find hidden genetic changes that cause drug resistance. The goal is to uncover new ways to treat these resistan…
Matched conditions: KRAS G12C MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC